Last reviewed · How we verify

NCT03639285

Natural History, Diagnosis, and Outcomes for Leukodystrophies

Recruiting now Last updated 13 January 2026
What this trial tests

trial in Leukodystrophy in 600 participants. Currently enrolling.

Timeline
19 January 2007
Primary endpoint
31 December 2033
31 December 2050

Quick facts

Lead sponsorUniversity of Utah
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment600
Start date19 January 2007
Primary completion31 December 2033
Estimated completion31 December 2050
Sites1 location across United States

Conditions studied

Sponsor

University of Utah

Who can join

Eligibility, any sex, with Leukodystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Leukodystrophy

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03639285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing